NexgenRx Inc (NXG.V)

0.295 +0.02 (+5.36%) CAD  |  TSXV  |  Jan 08, 16:00
More

NexgenRx Max Drawdown (5Y): 57.14% for Dec. 31, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for NXG.V.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
ZoomMed Inc 66.67%
Extendicare Inc 46.28%
Sienna Senior Living Inc 53.17%
Medical Facilities Corp 87.22%
Dentalcorp Holdings Ltd --

Max Drawdown (5Y) Related Metrics

Alpha (5Y) 3.045
Beta (5Y) 0.4338
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 43.11%
Historical Sharpe Ratio (5Y) 0.161
Historical Sortino (5Y) 0.3502
Monthly Value at Risk (VaR) 5% (5Y Lookback) 15.15%